Corporate governance, strategic philanthropy, and public policy

Business Horizons

Volumn 42, Issue 3, 1999, Pages 57-62

  Hemphill, Thomas A ^a  

^a New Jersey State Department of Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033130266     PISSN: 00076813     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0007-6813(99)80022-6     Document Type: Article

References (12)

1. David P. Baron, "Integrated strategy: Market and nonmarket components," California Management Review, Winter 1995, pp. 47-65.
2. Debra E. Blum and Susan Gray, "Big business means big philanthropy," The Chronicle of Philanthropy, July 16, 1998, p. 1.
3. Adam Bryant, "Companies oppose idea of telling how they contribute to charities," The New York Times, April 3, 1998, p. A1.
4. Building relationships, ARCO Foundation Annual Report, 1997-1998.
5. Austin Fulk, Patterns of Corporate Philanthropy: Funding Enemies, Forsaking Friends, Capital Research Center, Washington, D.C., Studies in Philanthropy #21, 1996.
6. Beverly Goodman, "Nonprofits fear decline in corporate donations," The Nonprofit Times, March 1998, p. 4.
7. Daniel Kadlec, "The new world of giving: Companies are doing more good and demanding more back," Time, May 5, 1997, pp. 63-64.
8. Ann E. Kaplan (ed.), Giving USA 1998: The Annual Report on Philanthropy for the Year 1997 (New York: AAFRC Trust for Philanthropy, 1998).
9. Patricia F. Lewis, President & CEO, National Society of Fund Raising Executives, letter (via e-mail) to Jonathan G. Katz, Secretary, U.S. Securities and Exchange Commission, Washington, D.C., November 12, 1997.
10. Steven Paprocki, National Committee for Responsive Philanthropy/Minnesota, letter (via e-mail) to Jonathan G. Katz, Secretary, U.S. Securities and Exchange Commission, Washington, D.C., November 12, 1997.
11. Pfizer philanthropy, Corporate Philanthropy Report 1996/97, Pfizer Inc. & the Pfizer Foundation Inc.
12. Allan Sloan, "Can need trump greed?" Newsweek, April 28, 1997, pp. 34, 36.